Inventor · disambiguated record
Robert Sackstein
Also filed as: SACKSTEIN ROBERT
21 granted patents·21 pending applications·65 citations·filing 2001–2024
93Inventor score
Files withSACKSTEIN ROBERT24VELICO MEDICAL INC7BRIGHAM & WOMENS HOSPITAL INC3THE BRIGHAM AND WOMENS HOSPITAL3THE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES2
Top patents by PatentIndex Score
42 records- 0193US8084236B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2007·Granted Dec 27, 2011·18 cites·51 claims
- 0288US7998740B2Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2007·Granted Aug 16, 2011·9 cites·13 claims
- 0388US7816500B2Antibody SACK-1 that binds CD44 glycoformsSACKSTEIN ROBERT·Filed 2009·Granted Oct 19, 2010·7 cites·2 claims
- 0487US8728810B2Methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2011·Granted May 20, 2014·7 cites·27 claims
- 0581US8852935B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2011·Granted Oct 7, 2014·3 cites·19 claims
- 0681US7875585B2Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptideSACKSTEIN ROBERT·Filed 2001·Granted Jan 25, 2011·11 cites·11 claims
- 0780US9788539B2Platelet protection solution having beta-galactosidase and sialidase inhibitorsVELICO MEDICAL INC·Filed 2016·Granted Oct 17, 2017·1 cites·25 claims
- 0879US12090173B2Methods to improve cell therapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Granted Sep 17, 2024·0 cites·15 claims
- 0979US9523078B2Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptideSACKSTEIN ROBERT·Filed 2012·Granted Dec 20, 2016·3 cites·16 claims
- 1074US11535831B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2020·Granted Dec 27, 2022·0 cites·20 claims
- 1172US10370642B2Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectinSACKSTEIN ROBERT·Filed 2015·Granted Aug 6, 2019·1 cites·9 claims
- 1271US10271541B2Platelet additive solution having a beta-galactosidase inhibitorVELICO MEDICAL INC·Filed 2017·Granted Apr 30, 2019·1 cites·16 claims
- 1370US2023310602A1Compositions and methods for treatment of inflammatory disordersSACKSTEIN ROBERT·Filed 2022·Application pending·0 cites
- 1470US2020281985A1Methods to improve cell therapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 1567US9914913B2Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2014·Granted Mar 13, 2018·0 cites·8 claims
- 1666US2024272156A1Compositions and methods for identifying and isolating human hematopoietic stem and progenitor cellsTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2024·Application pending·0 cites
- 1764US9609861B2Platelet additive solution having a β-galactosidase inhibitorVELICO MEDICAL INC·Filed 2013·Granted Apr 4, 2017·1 cites·18 claims
- 1864US2018127731A1Compositions and methods for modifying cell surface glycansSACKSTEIN ROBERT·Filed 2018·Application pending·0 cites
- 1962US2019200602A1Platelet Additive Solution Having a Beta-Galactosidase InhibitorVELICO MEDICAL INC·Filed 2019·Application pending·0 cites
- 2061US7098195B2Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cellsBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Aug 29, 2006·3 cites·26 claims
- 2161US2014199316A1Methods of treating complications and disorders associated with g-csf administrationSACKSTEIN ROBERT·Filed 2014·Application pending·0 cites
- 2261US2019246629A1Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase InhibitorVELICO MEDICAL INC·Filed 2019·Application pending·0 cites
- 2361US2018000066A1Platelet Protection Solution Having Beta-Galactosidase and Sialidase InhibitorsVELICO MEDICAL INC·Filed 2017·Application pending·0 cites
- 2459US12486298B2Fucosyltransferase specific inhibition using fucose mimeticsTHE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES·Filed 2022·Granted Dec 2, 2025·0 cites·13 claims
- 2558US11939616B2Compositions and methods for enforcing fucosylation of lactosaminyl glycans in human cells with alpha(1,3)-fucosyltransferasesTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2020·Granted Mar 26, 2024·0 cites·4 claims
- 2658US8765126B2Methods of treating complications and disorders associated with G-CSF administrationSACKSTEIN ROBERT·Filed 2012·Granted Jul 1, 2014·0 cites·14 claims
- 2758US2016000064A1Platelet Storage and Reduced Bacterial Proliferation in Platelet Products Using a Sialidase InhibitorVELICO MEDICAL INC·Filed 2015·Application pending·0 cites
- 2856US8633026B2Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2011·Granted Jan 21, 2014·0 cites·20 claims
- 2956US2013058959A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2012·Application pending·0 cites
- 3056US2014170120A1Cytokine induction of selectin ligands on cellsSACKSTEIN ROBERT·Filed 2014·Application pending·0 cites
- 3154US10471103B2Methods to improve cell therapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2015·Granted Nov 12, 2019·0 cites·5 claims
- 3254US2021123024A1Compositions and methods for production of exofucosylated cells for clinical applicationsTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2020·Application pending·0 cites
- 3354US2006210558A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2005·Application pending·0 cites
- 3453US2011189139A1Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 PolypeptideSACKSTEIN ROBERT·Filed 2011·Application pending·0 cites
- 3553US2016194376A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2015·Application pending·0 cites
- 3651US11517580B2Fucosyltransferase specific inhibition using fucose mimeticsTHE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES·Filed 2020·Granted Dec 6, 2022·0 cites·12 claims
- 3748US2012321601A1Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase InhibitorLIU QIYONG PETER·Filed 2012·Application pending·0 cites
- 3847US2005214283A1Antibodies to CD44 glycoforms and uses thereofSACKSTEIN ROBERT·Filed 2004·Application pending·0 cites
- 3945US2019201444A1Glycoengineering of e-selectin ligandsSACKSTEIN ROBERT·Filed 2017·Application pending·0 cites
- 4045US2006281708A1Fluorinated glucosamine analogs useful for modulating post-translational glyscosylations on cellsHEALTH RESEARCH INC·Filed 2006·Application pending·0 cites
- 4143US2013059333A1Hematopoietic cell selectin ligand polypeptides and methods of use thereofSACKSTEIN ROBERT·Filed 2012·Application pending·0 cites
- 4241US2006003924A1Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereofSACKSTEIN ROBERT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Sackstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →